Impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy – lipid metabolism as a novel biomarker to predict prostate cancer progression – phase 3, double-blind randomized clinical trial ESTO2/FinnProstata XV

Startår

2024

Beviljade finansiering

Teemu Murtola

300 000 €

---

Finansiär

Cancerstiftelsen sr.

Utlysning

Tutkimusapuraha 2024

Övriga uppgifter

Finansieringsbeslutets nummer

A2875

Vetenskapsområden

Cancersjukdomar